Navigation Links
Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
Date:9/4/2007

MIAMI LAKES, Fla., Sept. 4 /PRNewswire/ -- In an extensive analysis of clinical trials known as a meta-analysis, the CYPHER(R) Sirolimus-eluting Coronary Stent was associated with significantly lower risks of blood clots and the need for reintervention compared to the Taxus Stent out to 30 months after an angioplasty procedure. This meta-analysis of 16 randomized clinical trials and 8,695 patients, the largest analysis of its kind to date, is now posted on the Journal of the American College of Cardiology website and is expected in print later in the year.

"Over the past year, concerns have been raised regarding the long-term safety of all drug-eluting stents," said Professor Albert Schomig, M.D., from Deutsches Herzzentrum, Technische Universitat in Munich, Germany, one of the authors of the study. "In this meta-analysis of randomized controlled trials, the CYPHER(R) Stent was associated with a significant reduction in the risks of stent thrombosis and reintervention compared to the Taxus Stent. This reinforces the notion that there are marked differences between the CYPHER(R) Stent and the Taxus Stent and that the safety of these drug-eluting stents must be assessed separately."

Professor Schomig added, "We find these data compelling because they are consistent with other documented meta-analyses and reflect data from all of the randomized clinical trials directly comparing these drug-eluting stents. Meta-analyses like this are an important and well-accepted statistical method among clinicians worldwide for documenting similarities and differences between two treatment modalities. We understand and appreciate that such studies are open to various interpretations by researchers and clinicians."

The primary safety endpoint of the meta-analysis was protocol-defined stent thrombosis while the secondary safety endpoints were death and heart attack (myocardial infarction or MI). The primary efficacy endpoint was the need for reintervention (targ
'/>"/>

SOURCE Cordis Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Today Eli Lilly and Company (NYSE: LLY ... to increase the global supply of medicines for multidrug-resistant ... donating manufacturing technology and know-how for two antibiotics to ... India , Russia ... MDR-TB ,hot spots., It also served as the foundation ...
(Date:10/27/2014)... Research and Markets has announced the addition of ... their offering. H1N1 influenza (zoonotic) is an ... swine H1N1 virus, known as H1N1v virus. The H1N1v virus ... H1N1 virus is an RNA virus belonging to the Orthomyxoviridae ... humans, swine, birds, seals, and horses. Influenza A viruses can ...
(Date:10/27/2014)... EAST TAUNTON, Mass. , Oct. 27, 2014 /PRNewswire/ ... the $15 billion global hip and knee replacement device market, ... and knee replacement technology at the American Association of ... the Sheraton Dallas Hotel in Dallas, Texas ... is a Bronze corporate partner of the organization. ...
Breaking Medicine Technology:Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3
... , LAKE FOREST, Ill. , Jan. 12 ... of injectable pharmaceuticals announced today the launch of Ibutilide ... from Pfizer Inc. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO ) , ... Pharma,s continued growth and dedication to a consistently expanding ...
... Jan. 12 CVS Caremark Corporation (NYSE: CVS ) ... quarterly dividend of approximately 15%, to 8.75 cents per share on ... holders of record on January 22, 2010 . This increase translates into ... cents per share from the previous rate of 30.5 cents . ...
Cached Medicine Technology:Bioniche Pharma Launches Ibutilide Fumarate Injection 2CVS Caremark Corporation Increases Quarterly Dividend 15% 2
(Date:10/30/2014)... Timothy, InstaKNOT’s 4-year-old CEO, plans ... that you are never too young to give back ... and Carl at the 2013 Santa Arriving By Helicopter ... Chamber of Commerce. Tracey gave Timothy a special tour ... his real fireman’s hat, and extending an offer to ...
(Date:10/30/2014)... PreDiabetes Centers , the pioneer ... shoppers with a supply of sugardown®, a chewable dietary ... blood sugar spikes. Learning how to control blood sugar ... of a diabetes prevention plan. , Shoppers who spend ... tube of sugardown. The offer expires November 30. ...
(Date:10/30/2014)... Dennis Thompson HealthDay ... The Ebola outbreak in Liberia -- one of three West ... World Health Organization officials said Wednesday. Dr. Bruce Aylward, ... the number of burials in Liberia and no increase in ... global push to tame the epidemic may be making some ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 ... Commission Accredited teleradiology and specialty telemedicine solutions provider, ... addition to its existing teleradiology services at Mission ... opinion and expert telemedicine services, to the state-of-the-art, ... As a result of this innovative partnership, there ...
(Date:10/30/2014)... Sound Telecom, a leader in the call ... people any time they wonder, “Should I use an answering ... leading them through a series of yes or no questions ... , There are many considerations and scenarios that come into ... answering service . This decision infographic serves as a bit ...
Breaking Medicine News(10 mins):Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2
... ... to Walk with Style , ... Portland, OR (PRWEB) March 31, 2010 -- Pat Heyward Canes, a new provider of fashion ... designer patterns for men and women ranging from classic to whimsical. Made from performance ...
... ... efforts , ... Lake City, UT (Vocus) March 31, 2010 -- Venafi, Inc. ( www.venafi.com ) today ... when encryption keys are not properly monitored and managed., , ,Visit this link to ...
... ... for its innovative work in bringing about positive, scalable community-led change in thousands of ... ... named nonprofit Tostan as a 2010 recipient of its prestigious Skoll ...
... believed to bear fruit that ripened into a living baby ... as new treatments for osteoporosis, the bone-thinning disease. That,s the ... of Natural Products . Young Ho Kim and ... affecting up to 6 million women and 2 million men ...
... popular imaging procedures such as virtual colonoscopy , WEDNESDAY, ... imaging technologies are exposing Americans to too much radiation ... U.S. Food and Drug Administration concludes two days of ... increase the safety of these procedures. , Specifically, the ...
... ... Deliver Critical Support for Users of Chemicals , ... Vancouver, WA and Tampa, FL (PRWEB) March 31, 2010 ... ChemTel, Inc., the nation’s premiere emergency response support center, are pleased to announce a ...
Cached Medicine News:Health News:Pat Heyward Canes Unveils New Stylish Walking Cane Collection Just in Time for Mother's Day 2Health News:PCI Compliance and Data Security Requires Private Key Management – New Industry White Paper Explains 2Health News:Tostan and Molly Melching Receive 2010 Skoll Award for Social Entrepreneurship 2Health News:Tostan and Molly Melching Receive 2010 Skoll Award for Social Entrepreneurship 3Health News:Tostan and Molly Melching Receive 2010 Skoll Award for Social Entrepreneurship 4Health News:FDA Hears Views on Risks of High Tech Scanners 2Health News:FDA Hears Views on Risks of High Tech Scanners 3Health News:FDA Hears Views on Risks of High Tech Scanners 4Health News:Safetec and ChemTel Announce Partnership 2Health News:Safetec and ChemTel Announce Partnership 3
... The pause of a heartbeat. The bodys ... rhythmic breathing. These vital signs are yours ... DeRoyals line of Temperature Monitoring products helps ... information needed to provide the most comfortable ...
... Excilite- is a portable, compact, lightweight ... capable of emitting the same intensity (50 ... on a smaller treatment area (30 cm). ... order to satisfy the most demanding professional ...
... system used in neurophysiology for studying evoked potentials. ... and/or the duration of the stimulus as well ... emission in an ongoing manner by acting on ... include the high repeatability of the impulses, the ...
... 1.0 is a high power pulsed ... response to pain, even in the ... differs from the other laser devices ... full safety, all the 3 laser ...
Medicine Products: